ArticleDermatology practical & conceptual2025
Comparative Study of CO
Article in Dermatology practical & conceptual, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionBasal cell carcinoma (BCC) is the most common type of skin cancer worldwide, and the incidence is rising. While surgical excision remains the gold standard, it can be time-consuming and resource-intensive. Therefore, there is a growing need for simpler and more cost-effective treatment options for low-risk tumors.
objectivesThis study compared the scar quality and the recurrence rate from continuous wave CO
methodsA single-blind randomized prospective interventional trial was conducted at Odense University Hospital, Denmark, from 2017 to 2023. Patients with histologically confirmed superficial BCC were randomized 1:1 to Curettage-Electrodesiccation (CE) or continuous wave CO
resultsThirty-two patients were treated for 32 tumors: 17 with CE and 15 with CO
conclusionCO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.